- Xtant Medical press release (NYSE:XTNT): Q2 GAAP EPS of $0.02 beats by $0.03.
- Revenue of $35.4M beats by $4.05M.
- Gross margin of 68.6% compared to 62.1% for the prior year quarter
- Net income of $3.6 million compared to a net loss
Xtant Medical GAAP EPS of $0.02 beats by $0.03, revenue of $35.4M beats by $4.05M

Related
Venture Global wins arbitration case against Shell in LNG co...
21 minutes ago
0
CarParts.com signals $10M annualized savings and advances st...
34 minutes ago
0
DuPont’s electronics spinoff Qnity prices $4.1B debt deal ah...
42 minutes ago
0
Exclusive: Top crypto VC Matt Huang to lead Stripe blockchai...
54 minutes ago
0
IPM aims for adjusted EBITDA positivity by early 2026 while ...
55 minutes ago
0
Meren Energy Inc. GAAP EPS of $0.00
55 minutes ago
0
GINSMS reports Q2 results
58 minutes ago
0
Vision Marine Technologies files to sell 1.88M shares of com...
59 minutes ago
0
Brown & Brown acquires the assets of Tire Shield
1 hour ago
0
Allogene Therapeutics Q2 2025 Earnings Preview
1 hour ago
0
Fossil Q2 2025 Earnings Preview
1 hour ago
0
Crescent Capital BDC Q2 2025 Earnings Preview
1 hour ago
0
Raytheon awarded $258.74M U.S. Navy contract
1 hour ago
0
Mexco Energy GAAP EPS of $0.12
1 hour ago
0
Sky Harbour Group reports Q2 results
1 hour ago
0
Trending
Popular
عکس پربازدید از فرزند تازه متولد شده پیمانقاسمخانی
23 hours ago
4
© FBT Company 2025. All rights are reserved